Seroprevalence and severity of 2009 pandemic influenza a H1N1 in Taiwan

PLoS ONE

Volumn 6, Issue 9, 2011, Pages

  Chen, Chih Jung ^a,d   Lee, Ping Ing ^b   Chang, Shih Cheng ^c,d   Huang, Yhu Chering ^a,d   Chiu, Cheng Hsun ^a,d   Hsieh, Yu Chia ^a,d   Chang, Shang Chwen ^b   Chang, Feng Yee ^e   Lee, Jen Jyh ^f   Su, Shey Chiang ^g   Shen, Gwan Han ^h   Chuang, Yin Ching ⁱ   Chen, Yao Shen ^j,k   Liu, Jien Wei ^c   Lin, Tzou Yien ^a,d  

^a CHANG GUNG CHILDREN S HOSPITAL   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^c CHANG GUNG UNIVERSITY   (Taiwan)

^d CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

^e CENTER FOR DISEASE CONTROL   (Taiwan)

^f TZU CHI UNIVERSITY   (Taiwan)

^g MACKAY MEMORIAL HOSPITAL   (Taiwan)

^h TAICHUNG VETERANS GENERAL HOSPITAL   (Taiwan)

ⁱ CHI MEI MEDICAL CENTER   (Taiwan)

^j KAOHSIUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^k NATIONAL YANG MING UNIVERSITY   (Taiwan)

more..

Author keywords

[No Author keywords available]

Indexed keywords

2009 H1N1 INFLUENZA; ADOLESCENT; ADULT; AGE; AGED; ARTICLE; CHILD; CHILD CARE; CONTROLLED STUDY; DISEASE SEVERITY; DISEASE SURVEILLANCE; ELDERLY CARE; FATALITY; HEMAGGLUTINATION INHIBITION TEST; HUMAN; INFANT; INFECTION PREVENTION; INFECTION RATE; INFLUENZA VACCINATION; MAJOR CLINICAL STUDY; PRESCHOOL CHILD; SCHOOL CHILD; SEROPREVALENCE; TAIWAN; DEMOGRAPHY; EPIDEMIOLOGY; FEMALE; HEALTH SURVEY; HOSPITALIZATION; IMMUNOLOGY; INFLUENZA; INFLUENZA VIRUS A H1N1; MALE; MIDDLE AGED; PANDEMIC; PHYSIOLOGY; STATISTICS; VACCINATION; VIROLOGY;

ADOLESCENT; ADULT; AGED; CHILD; CHILD, PRESCHOOL; DEMOGRAPHY; FEMALE; HEMAGGLUTINATION INHIBITION TESTS; HUMANS; INFANT; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA, HUMAN; MALE; MIDDLE AGED; PANDEMICS; POPULATION SURVEILLANCE; SEROEPIDEMIOLOGIC STUDIES; SEVERITY OF ILLNESS INDEX; TAIWAN; VACCINATION; YOUNG ADULT;

EID: 80052354985     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0024440     Document Type: Article

References (33)

1. Center for Disease Control and Prevention (2009) Swine influenza A (H1N1) infection in two-children Southern California, March-April 2009. Morb Mortal Wkly Rep 58: 400-402.
2. Center for Disease Control and Prevention (2009) Outbreak of swine-origin influenza A (H1N1) virus infection- Mexico, March-April 2009. Morb Mortal Wkly Rep 58: 467-470.
3. European Centre for Disease Prevention and Control Technical Emergency Team (2009) Initial epidemiological findings in the European Union following the declaration of pandemic alert level 5 due to influenza A (H1N1). Euro Surveill 14 8 Available: http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=19204 Accessed 2011 Feb.
4. European Centre for Disease Prevention and Control Technical Emergency Team (2009) Pandemic phase level 4: human cases of the novel influenza A/H1N1 strain confirmed in Scotland and Spain. Euro Surveill 14 8 Available: http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=19185 Accessed 2011 Feb.
5. Center for Disease Control and Prevention. (2009) Swine-origin influenza A (H1N1) virus infections in a school- New York City, April 2009. Morb Mortal Wkly Rep 58: 470-472.
6. World Health Organization. (2009) World now at the start of 2009 influenza pandemic; Statement to the press by WHO Director-General Dr Margaret Chan. 28 Available: http://www.who.int/mediacentre/news/statements/2009/h1n1_pandemic_phase6_20090611/en/index.html. Accessed 2011 June.
7. Wu JT, Ma ESK, Lee CK, Chu DKW, Ho P-L, et al. (2010) The infection attack rate and severity of 2009 pandemic H1N1 influenza in Hong Kong. Clin Infect Dis 51: 1184-1191.
8. Zimmer SM, Crevar CJ, Carter DM, Stark JH, Giles BM, et al. (2010) Seroprevalence following the second wave of Pandemic 2009 H1N1 influenza in Pittsburgh, PA, USA. PLoS ONE 5: e11601.
9. Tilston NL, Eames KT, Paolotti D, Ealden T, Edmunds WJ, (2010) Internet-based surveillance of Influenza-like-illness in the UK during the 2009 H1N1 influenza pandemic. BMC Public Health 10: 650.
10. European Centre for Disease Prevention and Control Technical Emergency Team (2009) Progression and impact of the first winter wave of the 2009 pandemic H1N1 influenza in New South Wales, Australia. Euro Surveill 14 8 Available: http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=19365 Accessed 2011 Feb.
11. Miller E, Hoschler K, Hardelid P, Stanford E, Andrews N, et al. (2010) Incidence of 2009 pandemic influenza A H1N1 infection in England: a cross-sectional serological study. Lancet 375: 1100-1108.
12. Skowronski D, Hottes T, Janjua N, Purych D, Sabaiduc S, et al. (2010) Prevalence of seroprotection against the pandemic (H1N1) virus after the 2009 pandemic. Can Med Assoc J 182: 1851-1856.
13. McVernon J, Laurie K, Nolan T, Owen R, Irving D, et al. (2010) Seroprevalence of 2009 pandemic influenza A(H1N1) virus in Australian blood donors, October- December 2009. Euro Surveill 15 8 Available: http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=19678 Accessed 2011 Feb.
14. Adamson WE, Maddi S, Robertson C, McDonagh S, Molyneaux PJ, et al. (2010) 2009 pandemic influenza A(H1N1) virus in Scotland: geographically variable immunity in Spring 2010, following the winter outbreak. Euro Surveill 15 8 Available: http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=19590 Accessed 2011 Feb.
15. Chowell G, Bertozzi SM, Colchero MA, Lopez-Gatell H, Alpuche-Aranda C, et al. (2009) Severe respiratory disease concurrent with the circulation of H1N1 influenza. N Engl J Med 361: 674-679.
16. Kumar A, Zarychanski R, Pinto R, Cook DJ, Marshall J, et al. (2009) Critically ill patients with 2009 influenza A(H1N1) infection in Canada. JAMA 302: 1872-1879.
17. Chang SC, Chang CM, Huang YC, Chiu CH, Shih SR, et al. (2010) Preexisting antibodies against pandemic 2009 influenza A (H1N1) virus in Taiwan. Clin Infect Dis 51: 1465-1467.
18. Chen H, Wang Y, Liu W, Zhang J, Dong B, et al. (2009) Serologic survey of pandemic (H1N1) 2009 virus, Guangxi Province, China. Emerging Infect Dis 15: 1849-1850.
19. Chen MI, Lee VJ, Lim WY, Barr IG, Lin RT, et al. (2010) 2009 influenza A(H1N1) seroconversion rates and risk factors among distinct adult cohorts in Singapore. JAMA 303: 1383-1391.
20. Itoh Y, Shinya K, Kiso M, Watanabe T, Sakoda Y, et al. (2009) In vitro and in vivo characterization of new swine-origin H1N1 influenza viruses. Nature 460: 1021-1025.
21. Allwinn R, Geiler J, Berger A, Cinatl J, Doerr HW, (2010) Determination of serum antibodies against swine-origin influenza A virus H1N1/09 by immunofluorescence, haemagglutination inhibition, and by neutralization tests: how is the prevalence rate of protecting antibodies in humans? Med Microbiol Immunol 199: 117-121.
22. Hancock K, Veguilla V, Lu X, Zhong W, Butler EN, et al. (2009) Cross-reactive antibody responses to the 2009 pandemic H1N1 influenza virus. N Engl J Med 361: 1945-1952.
23. Bandaranayake D, Huang QS, Bissielo A, Wood T, Mackereth G, et al. (2010) Risk factors and immunity in a nationally representative population following the 2009 influenza A(H1N1) pandemic. PLoS ONE 5: e13211.
24. Naitonal Center for Immunization and Respiratory Diseases, Center for Disease Control and Prevention. (2009) Use of influenza A (H1N1) 2009 monovalent vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2009. Morb Mortal Wkly Rep 58: 1-8.
25. Donaldson LJ, Rutter PD, Ellis BM, Greaves FE, Mytton OT, et al. (2009) Mortality from pandemic A/H1N1 2009 influenza in England: public health surveillance study. BMJ 339: b5213.
26. Wu U-I, Liu M-T, Wang J-T, Hsieh S-M, Chang S-C, et al. (2010) Serological response to H1N1 influenza virus infections in adults treated with oseltamivir. Clin Infect Dis 51: 1223-1225.
27. Hung Ivan FN, To Kelvin KW, Lee CK, Lin CK, Chan Jasper FW, et al. (2010) Effect of Clinical and Virological Parameters on the Level of Neutralizing Antibody against Pandemic Influenza A Virus H1N1 2009. Clin Infect Dis 51: 274-279.
28. Janjua Naveed Z, Skowronski Danuta M, Hottes Travis S, Osei W, Adams E, et al. (2010) Seasonal Influenza Vaccine and Increased Risk of Pandemic A/H1N1-Related Illness: First Detection of the Association in British Columbia, Canada. Clin Infect Dis 51: 1017-1027.
29. Skowronski DM, De Serres G, Crowcroft NS, Janjua NZ, Boulianne N, et al. (2010) Association between the 2008-09 seasonal influenza vaccine and pandemic H1N1 illness during Spring-Summer 2009: four observational studies from Canada. PLoS Med 7: e1000258.
30. Johns MC, Eick AA, Blazes DL, Lee SE, Perdue CL, et al. (2010) Seasonal influenza vaccine and protection against pandemic (H1N1) 2009-associated illness among US military personnel. In: Kendal AP, Pereira MS, editors. PLoS One JJ S (1982) Concepts and procedures for laboratory-based influenza surveillance. Atlanta, GA: US Department of Health and Human Services, CDC 5: e10722.31.
31. Kendal AP, Pereira MS, JJ S, (1982) Concepts and procedures for laboratory-based influenza surveillance. Atlanta, GA US Department of Health and Human Services, CDC.
32. World Health Organization (2002) World Health Organization manual on animal influenza diagnosis and surveillance. Geneva, Switzerland.
33. Huang WT, Hsu CC, Lee PI, Chuang JH, (2010) Mass psychogenic illness in nationwide in-school vaccination for pandemic influenza A(H1N1) 2009, Taiwan, November 2009-January 2010. Euro surveillance 15: 19575.